Does AHR pay a dividend and is it safe?

American Healthcare REIT Inc. (AHR) offers a 1.32% cash dividend yield ($0.71 annualized) and 1.92% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.

Stock Ratings / Financials / AHR / dividends

DOC (58) SUI (62) ELS (62) MAA (60) ⌘ Pro Terminal →

American Healthcare REIT Inc. (AHR) Dividend Safety Gauge & 10-Year DRIP Compounder

$53.79 +0.50% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $53.74

American Healthcare REIT Inc. (AHR) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $12.48B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on AHR Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is AHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, American Healthcare REIT Inc. (NYSE: AHR) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 65/100 at a spot price of $53.79 (+0.50% 1D, market cap $12.48B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 15/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 12/20. Across 1097 tracked Financials issuers, AHR ranks #231 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does AHR compare to DOC and SUI in the Financials sector?

▼

Within the Financials sector (Real Estate Investment Trusts), AHR carries a Roarable C (65/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 8.1%. By comparison, DOC (Healthpeak Properties Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC 0.6%, cap $13.12B) and SUI (Sun Communities Inc.) posts a C grade (62/100 RQD, P/E 9.5x, ROIC 15.9%, cap $13.52B). Among the 5-stock peer group, SUI leads on earnings multiple (9.5x) while SUI leads on capital efficiency (15.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for AHR?

▼

Per AHR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001632970), American Healthcare REIT Inc. generated $2.09B in revenue (+11.2% YoY), $70.8M in net income, and $200.2M in free cash flow against $5.43B in total assets and $929.5M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $53.74 (-0.10%)🧬 Disciplined Float (-0.04% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 9.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 65/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.3% avg 90D alpha vs SPY • 55.6% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C+

Each axis scored 0–20

12M PRICE TARGET CONE+3.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AHR)Realized 20D OHLCV Swing Band: ±5.9%

Deterministic 5-Pillar Attribution (65/100 Composite)

🔍 WHY AHR SCORES 65/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Whale & Options Positioning+14/20 pts (22% of score)

20D Institutional Volume Accumulation (±5.9% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution12/20 pts (-8 pt drag)

Disciplined Float (-0.04% YoY Shares) & executive Form 4 sales trim 8 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$52.42+0.8% Next Q

Q2 (-2Q)

Grade C$52.86-2.6% Next Q

Q3 (-1Q)

Grade C+$51.50+4.4% Next Q

Current

Grade C$53.79+1.3% Hist 90D α

Trajectory: C (57) → C (65)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the AHR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 65/100 (C) score, AHR faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.04% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($52.97) or 200D SMA ($51.55) invalidates the momentum regime and cuts Target Base ($55.48) toward Bear Floor ($43.27).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AHR• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “AHR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 65%NO 35%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.92% Total Yield

1.32% Cash ($0.71/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

88/100 • FORTRESS PAYOUT

FREE CASH FLOW PAYOUT RATIO

53% of FCF

8 consecutive years of payout growth

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (8.1% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $21,790

Est. Year-10 Shareholder Yield: $418/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.8K

Yr 1

$11.7K

Yr 2

$12.6K

Yr 3

$13.7K

Yr 4

$14.8K

Yr 5

$16.0K

Yr 6

$17.2K

Yr 7

$18.6K

Yr 8

$20.2K

Yr 9

$21.8K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in AHR & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on AHR and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AHR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.30%⚡ TESTING RESISTANCE

2026-11-03O $52.94H $53.79L $52.94C $53.79VOL 2.91M

RES: $54.10SUP: $47.82SMA50: $52.97SMA200: $51.55

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AHR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AHR Butterfly Map → + Track AHR →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

25.5%/yr Implied 5Y Growth

vs. +11.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on AHR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AHR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AHR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AHR)

Financials Rank #231 of 1097 ⚔️ DOC vs AHR Full Matrix →

1. Head-to-Head Financials Peer Comparison (AHR vs. DOC, SUI, ELS, MAA)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, American Healthcare REIT Inc. (AHR) ranks #231 by composite RQD confidence (65/100, grade C) and #160 by equity capitalization ($12.48B). Within this direct 5-issuer industry benchmark cohort, SUI leads on earnings valuation at 9.5x trailing P/E, while SUI leads on capital efficiency and profitability with 15.9% ROIC and — gross margin. AHR currently leads its immediate peer cohort in composite quantitative strength at 65/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AHR ACTIVE American Healthcare REIT Inc.	C	65/100	—	—	8.1%	+0.50%	$12.48B	Benchmark Subject
DOC Healthpeak Properties Inc.	D+	58/100	—	—	0.6%	+2.37%	$13.12B	/doc-vs-ahr →
SUI Sun Communities Inc.	C	62/100	9.5x	—	15.9%	+3.13%	$13.52B	/sui-vs-ahr →
ELS Equity Lifestyle Properties Inc.	C	62/100	28.5x	—	11.4%	+2.41%	$11.50B	/els-vs-ahr →
MAA Mid-America Apartment Communities Inc.	C-	60/100	30.7x	—	5.3%	+0.96%	$13.60B	/maa-vs-ahr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001632970 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), American Healthcare REIT Inc. (AHR) reported GAAP revenue of $2.09B (+11.2% vs. FY2024 revenue of $1.88B , and +25.5% cumulative change since FY2023) , GAAP net income of $70.8M, operating cash flow of $294.4M, and free cash flow of $200.2M (+119.2% YoY). On the balance sheet, AHR closed FY2025 with $5.43B in total assets against $929.5M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$2.09B	$70.8M	$294.4M	$200.2M	$5.43B	$929.5M
FY2024 (FY)	2024-12-31	$1.88B	-$35.6M	$176.1M	$91.3M	$4.49B	$982.8M
FY2023 (FY)	2023-12-31	$1.67B	-$76.9M	$98.5M	$23.4M	$6.79B	$1.59B

3. AHR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does AHR compare to DOC and SUI in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for AHR?

Where is AHR trading relative to its 50-day, 200-day, and 52-week technical levels?

AHR last traded at $53.79 (+0.50% on volume of 2,013,371 shares), positioning the stock +1.55% above its 50-day simple moving average ($52.97) and +4.35% above its 200-day simple moving average ($51.55). Across its 52-week range of $44.69 to $58.70, AHR sits at the 65.0% percentile with a 14-day RSI of 54.5 (NEUTRAL RANGE) and an implied next-earnings move of ±5.9% ($50.62 to $56.96).

Direct Sub-Reports: AHR RQD Cockpit AHR 12M Forecast AHR Earnings & Move AHR Dividends & DRIP AHR Insiders & 13F AHR Whale Options AHR Profit Sankey AHR News & Why

ROARABLE RATING BRIEF • RQD 65/100 (C) ✓ SEC XBRL & RQD VERIFIED

AHR — American Healthcare REIT Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

American Healthcare REIT Inc. (AHR) earns a live Roarable RQD composite score of 65/100, corresponding to a C letter grade (Roarable Hold) at a spot price of $53.79 (+0.50% 1D, market capitalization $12.48B).

Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of 8.1%, gross margin of —, operating margin of 19.8%, and free cash flow yield of 1.62%.
Whale 13F & Options Flow (14/20) + Insider Conviction (12/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (12/20) + Forensic Balance Sheet (15/20): Incorporates a 1.11x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 8/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Per the Financials sector classification, American Healthcare REIT Inc. (AHR) operates in the Real Estate Investment Trusts industry and is listed on the NYSE. It is a publicly traded US issuer with a market capitalization of $12.3B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), American Healthcare REIT Inc. (AHR) reported $2.09B in annual revenue (up from $1.88B in FY2024, +11.2% YoY) and $70.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.67B revenue, -$76.9M net income) through FY2025, AHR scaled operating cash flow to $294.4M and free cash flow to $200.2M, backed by $5.43B in total assets against $929.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (C • RQD 65/100): Clean SEC annual filing review with no major hidden accounting time-bombs. Free cash flow yield of 1.62% and institutional whale pillar of 14/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 14/20, sustained execution supports upside toward the upper end of the $44.69 – $58.70 52-week range.
🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh current valuation and 26.4x EV/EBITDA against 19.8% operating margins and a 1.11x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

— for upstream or downstream dependencies, sector correlations, or second-order bottlenecks. A prospective investor should note that the broader REIT sector's interest-rate sensitivity, implied by the 1.

Key Question #1: Can AHR sustain or expand its 19.8% operating margin and 8.1% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $2.09B and free cash flow of $200.2M, how will capital allocation balance growth reinvestment against $929.5M in total debt?
Key Question #3: How sensitive is AHR's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.11x)?

AHR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for American Healthcare REIT Inc. (AHR) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to AHR Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 23h ago

American Healthcare REIT, Inc. (AHR) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Here's Why American Healthcare REIT (AHR) is Poised for a Turnaround After Losing 7.8% in 4 Weeks

Yahoo Finance report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Investing.com • 1d ago

Raymond James initiates American Healthcare REIT stock at strong buy on Trilogy partnership

Investing.com report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

American Healthcare REIT, Inc. Estimates – BMV:AHR

TradingView report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

American Healthcare REIT, Inc. (NYSE:AHR) Stock Has Average Target Price of $62.75 According to Brokerages

MarketBeat report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 1d ago

American Healthcare REIT (AHR) Earnings Outlook Brightens, Is The Stock Cheap Or Pricey?

Simply Wall St report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 1d ago

American Healthcare REIT Inc (AHR) Cash Flow

TradingKey report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?

Yahoo Finance report covering American Healthcare REIT Inc. (AHR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

AHR Bull vs. Bear Conversation Board — What's Your Call at $53.79?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AHR 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $64.76 (+21.0%)

📌 Pinned Debate

Raymond James initiated coverage at strong buy on the Trilogy partnership while the forensic balance sheet scores strongly (Piotroski F

Raymond James initiated coverage at strong buy on the Trilogy partnership while the forensic balance sheet scores strongly (Piotroski F 8/9, Altman Z 2.5).. When you look under the hood at AHR, Fundamental Cash Engine is 12/20 with 0.0% gross margins and 8.1% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (14/20) has been quietly accumulating below $58.70. My 12M target is $64.76.

SectorRotator 🐂 BULL

@SiliconVal_Bull Agree on the RQD 65/100 quality, though with 1.11 beta I'm scaling in with half-size at $53.52 and keeping dry powder in case we test $49.77.

SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH 🎯 Target: $42.28 (-21.0%)

Spot @ $53.52

At an EV/EBITDA of 26.4 with only 1.62% FCF yield and 8.1% ROIC, the valuation leaves little margin for error.

Here is the bear case nobody on the bull side wants to address on AHR: At an EV/EBITDA of 26.4 with only 1.62% FCF yield and 8.1% ROIC, the valuation leaves little margin for error.. At current EV/EBITDA multiples, even a small guidance miss in Real Estate Investment Trusts triggers a 12-15% air pocket.